Survival and mortality in hemodialysis patients
Keywords:chronic kidney disease, end-stage renal failure, renal replacement therapy, hemodialysis, survival, mortality
This article provides a review of the literature on the problem of cardiovascular mortality in patients with end-stage renal disease. The article, based on foreign literature, considers the survival and mortality of hemodialysis patients. There is a high percentage of deaths due to cardiovascular pathologies in patients with end-stage renal disease receiving renal replacement therapy. The influence of cardiovascular pathologies on survival rates is described in detail according to the data of national and international renal registries. The data are provided on the study of the structure of the causes of death in hemodialysis patients. The factors influencing the survival rate and mortality in hemodialysis patients, such as smoking, preservation of diuresis, obesity, cholesterol concentration, serum potassium level, etc, are presented in detail. The urgency and necessity of studying this problem is noted, which dictates the need for purposeful efforts to reduce mortality in dialysis patients.
Farrington K, Covic A, Aucella F, et al. Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR <45 mL/min/1.73 m2). Nephrol Dial Transplant. 2016 Nov;31(Suppl 2):ii1-ii66. doi:10.1093/ndt/gfw356.
Van der Veer SN, van Biesen W, Bernaert P, et al. Priority topics for European multidisciplinary guidelines on the management of chronic kidney disease in older adults. Int Urol Nephrol. 2016 Jun;48(6):859-869. doi:10.1007/s11255-016-1257-4.
Nagler EV, Webster AC, Bolignano D, et al. European Renal Best Practice (ERBP) Guideline development methodology: towards the best possible guidelines. Nephrol Dial Transplant. 2014 Apr;29(4):731-738. doi:10.1093/ndt/gft407.
Smirnov AV, Dobronravov VA, Kayukov IG, Essaian AM. Chronic kidney disease: futher development of the conception and classification. Nephrology (Saint-Petersburg). 2007;11(4):7-17. doi:10.24884/1561-6274-2007-11-4-7-17. (in Russian).
Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013 Jan;3(1):1-150. doi:10.1038/kisup.2012.73.
United States Renal Data System (USRDS). USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD, United States: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; 2012.
Collins AJ, Foley RN, Gilbertson DT, Chen SC. United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease. Kidney Int Suppl (2011). 2015 Jun;5(1):2-7. doi:10.1038/kisup.2015.2.
Chen HS, Cheng CT, Hou CC, Liou HH, Lim PS. Survival and other clinical outcomes of maintenance hemodialysis patients in Taiwan: a 5-year multicenter follow-up study. Hemodial Int. 2014 Oct;18(4):799-808. doi:10.1111/hdi.12165.
Yamagata K, Nakai S, Iseki K, Tsubakihara Y; Committee of Renal Data Registry of the Japanese Society for Dialysis Therapy. Late dialysis start did not affect long-term outcome in Japanese dialysis patients: long-term prognosis from Japanese Society for [corrected] Dialysis Therapy Registry. Ther Apher Dial. 2012 Apr;16(2):111-120. doi:10.1111/j.1744-9987.2011.01052.x.
Gaipov A, Issanov A, Kadyrzhanuly K, et al. Epidemiology of dialysis-treated end-stage renal disease patients in Kazakhstan: data from nationwide large-scale registry 2014-2018. BMC Nephrol. 2020 Sep 21;21(1):407. doi:10.1186/s12882-020-02047-6.
Brener ZZ, Kotanko P, Thijssen S, Winchester JF, Bergman M. Clinical benefit of preserving residual renal function in dialysis patients: an update for clinicians. Am J Med Sci. 2010 May;339(5):453-456. doi:10.1097/MAJ.0b013e3181cf7d5b.
Shafi T, Jaar BG, Plantinga LC, et al. Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis. 2010 Aug;56(2):348-358. doi:10.1053/j.ajkd.2010.03.020.
Araujo S, Lemes HP, Cunha DA, Queiroz VS, Nascimento DD, Ferreira Filho SR. Cardiac morphology and function in patients with and without residual diuresis on hemodialysis. J Bras Nefrol. 2011 Mar;33(1):74-81.
Chen Y, Liu H, Zou J, et al. 24-h residual urine volume at hemodialysis initiation: a possible predictor for acute ischemic stroke incurrence in hemodialysis patients. Clin Neurol Neurosurg. 2013 May;115(5):557-561. doi:10.1016/j.clineuro.2012.06.028.
Amaral S, Hwang W, Fivush B, Neu A, Frankenfield D, Furth S. Serum albumin level and risk for mortality and hospitalization in adolescents on hemodialysis. Clin J Am Soc Nephrol. 2008 May;3(3):759-767. doi:10.2215/CJN.02720707.
Combe C, McCullough KP, Asano Y, Ginsberg N, Maroni BJ, Pifer TB. Kidney Disease Outcomes Quality Initiative (K/DOQI) and the Dialysis Outcomes and Practice Patterns Study (DOPPS): nutrition guidelines, indicators, and practices. Am J Kidney Dis. 2004 Nov;44(5 Suppl 2):39-46. doi:10.1053/j.ajkd.2004.08.010.
Cooper BA, Penne EL, Bartlett LH, Pollock CA. Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. Am J Kidney Dis. 2004 Jan;43(1):61-66. doi:10.1053/j.ajkd.2003.08.045.
Liebman SE, Lamontagne SP, Huang LS, Messing S, Bushinsky DA. Smoking in dialysis patients: a systematic review and meta-analysis of mortality and cardiovascular morbidity. Am J Kidney Dis. 2011 Aug;58(2):257-265. doi:10.1053/j.ajkd.2011.03.025.
Kessler M, Zannad F, Lehert P, et al. Predictors of cardiovascular events in patients with end-stage renal disease: an analysis from the Fosinopril in dialysis study. Nephrol Dial Transplant. 2007 Dec;22(12):3573-3579. doi:10.1093/ndt/gfm417.
Suvorov AV, Zubeeva GN, Suslova OA, et al. Heart rhythm disruption and cardiovascular risk in patients with terminal chronic kidney disease being on program hemodialysis. Practical medicine. 2013;(3):77-80. (in Russian).
Wang HH, Hung SY, Sung JM, Hung KY, Wang JD. Risk of stroke in long-term dialysis patients compared with the general population. Am J Kidney Dis. 2014 Apr;63(4):604-611. doi:10.1053/j.ajkd.2013.10.013.
Wu CK, Yang YH, Juang JJ, et al. Effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in dialysis patients: a nationwide data survey and propensity analysis. Medicine (Baltimore). 2015 Jan;94(3):e424. doi:10.1097/MD.0000000000000424.
Tang Y, Brooks JM, Wetmore JB, Shireman TI. Association between higher rates of cardioprotective drug use and survival in patients on dialysis. Res Social Adm Pharm. 2015 Nov-Dec;11(6):824-843. doi:10.1016/j.sapharm.2014.12.007.
Mokoli VM, Sumaili EK, Lepira FB, et al. Impact of residual urine volume decline on the survival of chronic hemodialysis patients in Kinshasa. BMC Nephrol. 2016 Nov 21;17(1):182. doi:10.1186/s12882-016-0401-9.
Bilevich OA, Ovsyannikov NV. Survival assessment of hemodialysis patients depending on the functional state parameters of cardiovascular system. Modern problems of science and education. 2015;(6):151. (in Russian).
Dalrymple LS, Mohammed SM, Mu Y, et al. Risk of cardiovascular events after infection-related hospitalizations in older patients on dialysis. Clin J Am Soc Nephrol. 2011 Jul;6(7):1708-1713. doi:10.2215/CJN.10151110.
Bradbury BD, Fissell RB, Albert JM, et al. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol. 2007 Jan;2(1):89-99. doi:10.2215/CJN.01170905.
Plantinga LC, Fink NE, Levin NW, et al. Early, intermediate, and long-term risk factors for mortality in incident dialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. Am J Kidney Dis. 2007 Jun;49(6):831-840. doi:10.1053/j.ajkd.2007.03.017.
Postorino M, Marino C, Tripepi G, Zoccali C; Calabrian Registry of Dialysis and Transplantation. Prognostic value of the New York Heart Association classification in end-stage renal disease. Nephrol Dial Transplant. 2007 May;22(5):1377-1382. doi:10.1093/ndt/gfl813.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
- The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.